New drug combo aims to shrink pancreatic tumors before surgery
NCT ID NCT04940286
Summary
This study is testing a four-drug combination given before surgery for pancreatic cancer that can be removed. The treatment includes two chemotherapy drugs and two immunotherapy drugs designed to help the immune system attack the cancer. The main goals are to see if this approach safely shrinks tumors and kills cancer cells before surgery, and to monitor patients for two years afterward.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.